Total Payments
$3,293
2024 Payments
$507.12
Companies
30
Transactions
204
Medicare Patients
1,388
Medicare Billing
$182,377
Payment Breakdown by Category
Food & Beverage$3,233 (98.2%)
Education$59.98 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,233 | 202 | 98.2% |
| Education | $59.98 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $409.97 | 33 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $330.18 | 21 | $0 (2024) |
| Alkermes, Inc. | $268.76 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $261.27 | 22 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $255.46 | 16 | $0 (2024) |
| ABBVIE INC. | $247.27 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $170.02 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $129.09 | 7 | $0 (2023) |
| ITI, Inc. | $117.52 | 5 | $0 (2023) |
| Shire North American Group Inc | $111.25 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $507.12 | 22 | Alkermes, Inc. ($136.29) |
| 2023 | $342.51 | 16 | Janssen Pharmaceuticals, Inc ($61.45) |
| 2022 | $359.35 | 18 | ABBVIE INC. ($73.90) |
| 2021 | $256.35 | 16 | AbbVie Inc. ($112.02) |
| 2020 | $277.72 | 16 | Allergan, Inc. ($70.03) |
| 2019 | $739.24 | 46 | Otsuka America Pharmaceutical, Inc. ($136.34) |
| 2018 | $432.96 | 36 | Allergan Inc. ($136.28) |
| 2017 | $377.41 | 34 | Allergan Inc. ($177.26) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: CNS | ||||||
| 10/08/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $30.07 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: CNS | ||||||
| 05/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuropsychiatry | ||||||
| 05/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: CNS | ||||||
| 04/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: CNS | ||||||
| 04/10/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Opioid Use Disorder | ||||||
| 04/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neurology | ||||||
| 03/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Neuropsychiatry | ||||||
| 02/27/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: CNS | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Opioid Use Disorder | ||||||
| 12/05/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: PSYCHOLOGY | ||||||
| 11/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 351 | 578 | $131,321 | $49,427 |
| 2022 | 9 | 407 | 667 | $115,382 | $50,601 |
| 2021 | 8 | 296 | 463 | $86,798 | $42,195 |
| 2020 | 11 | 334 | 500 | $95,837 | $40,154 |
Total Patients
1,388
Total Services
2,208
Medicare Billing
$182,377
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 202 | $51,106 | $17,881 | 35.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 111 | $22,311 | $10,302 | 46.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 117 | $16,380 | $7,290 | 44.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 62 | $16,492 | $6,102 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 51 | $9,129 | $3,186 | 34.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 22 | 22 | $10,846 | $2,880 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,057 | $1,785 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 167 | $32,738 | $14,461 | 44.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 97 | 216 | $28,194 | $12,060 | 42.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 82 | $15,266 | $6,648 | 43.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 63 | 64 | $11,622 | $4,975 | 42.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 35 | 35 | $9,895 | $4,672 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 62 | $8,398 | $3,687 | 43.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,118 | $1,498 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,048 | $1,490 | 48.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 15 | $3,103 | $1,111 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 198 | $37,620 | $18,298 | 48.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 31 | 31 | $8,153 | $4,821 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 59 | $7,611 | $3,585 | 47.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 25 | 25 | $6,575 | $3,471 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 37 | $6,845 | $3,046 | 44.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 52 | $6,708 | $2,979 | 44.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 23 | $5,952 | $2,851 | 47.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 23 | 26 | $5,174 | $2,179 | 42.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $2,160 | $965.88 | 44.7% |
About Dr. James Trahan, MD
Dr. James Trahan, MD is a Psychiatry healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699863019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Trahan, MD has received a total of $3,293 in payments from pharmaceutical and medical device companies, with $507.12 received in 2024. These payments were reported across 204 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,233).
As a Medicare-enrolled provider, Trahan has provided services to 1,388 Medicare beneficiaries, totaling 2,208 services with total Medicare billing of $182,377. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Kansas City, MO
- Active Since 10/11/2006
- Last Updated 10/02/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699863019
Products in Payments
- VRAYLAR (Drug) $654.86
- LATUDA (Drug) $261.27
- ARISTADA (Drug) $225.27
- Trintellix (Drug) $210.86
- REXULTI (Drug) $207.99
- CAPLYTA (Drug) $137.07
- AUSTEDO (Drug) $122.63
- ABILIFY MAINTENA (Drug) $120.01
- VYVANSE (Drug) $112.76
- SUNOSI (Drug) $89.16
- TRINTELLIX (Drug) $71.12
- SUBLOCADE (Drug) $61.47
- QELBREE (Drug) $59.88
- INVEGA SUSTENNA (Drug) $56.33
- Azstarys (Drug) $56.00
- Fanapt (Drug) $55.94
- BRIXADI (Drug) $53.92
- BELSOMRA (Drug) $52.63
- SPRAVATO (Drug) $52.43
- Qelbree (Drug) $50.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Kansas City
Dr. Brian Barash, M.d, M.D
Psychiatry — Payments: $825,527
Psychiatry $825,527
Debra Kelsh, M.d, M.D
Psychiatry — Payments: $36,659
Psychiatry $36,659
Mark Cannon, M.d, M.D
Psychiatry — Payments: $18,944
Psychiatry $18,944
Dr. Asim Ulusarac, M.d, M.D
Psychiatry — Payments: $12,464
Psychiatry $12,464
Dr. Tomas Brillantes, M.d, M.D
Psychiatry — Payments: $11,385
Psychiatry $11,385
Christine Trueblood, M.d, M.D
Psychiatry — Payments: $10,633
Psychiatry $10,633